Keros Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from various chronic respiratory diseases. The company’s innovative approach combines targeted therapies with precision medicine to improve patient outcomes and quality of life. With a strong pipeline of potential drug candidates, Keros Therapeutics Inc. is poised to make a significant impact on the future of respiratory medicine.
Notification